Skip to content
Home/Companies/HealthTech/Patient21
Patient21

Patient21

HealthTech·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Patient21?

Patient21 is a German HealthTech company, currently owned by Target Global since 2022.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Target Global
Investor
Target Global
Target Global Early Stage Fund III · 2022 · VC

Key facts

HQGermany
SectorHealthTech
StatusActive
Websitepatient21.com

More from Target Global Early Stage Fund III

Other portfolio companies in the same fund.

Robovision
Robovision
Active
AI/MLBelgium· 2024
Saleor
Active
SoftwarePoland/USA· 2024
Communion
Communion
Active
FintechUK· 2023
Enter
Enter
Active
SoftwareGermany· 2023
Ferry
Ferry
Active
AI/MLUK· 2023
Graphiti
Active
AI/MLIsrael· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Patient21?

Patient21 is currently owned by Target Global, through Target Global Early Stage Fund III, since 2022.

When did Target Global acquire Patient21?

Target Global acquired Patient21 in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue